Critical reflections on clinical trials
- 1 April 1983
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 2 (2) , 175-181
- https://doi.org/10.1002/sim.4780020211
Abstract
There is often concern about the large number of patients needed for a particular clinical trial. However, one could be equally concerned that a trial is designed with a number of patients that is too small to obtain a precise enough estimate of the difference between the success rates of the treatments. The design of the trial should ensure that statistical significance is only reached if the treatment difference exceeds a specified value of clinical importance. Designs with this property generally require more than the usual number of patients. It is hoped that discussion on the ethical acceptability of this consequence will be stimulated by this paper.Keywords
This publication has 6 references indexed in Scilit:
- Statistics in question. Assessing methods--art of significance testing.BMJ, 1981
- Statistics in question. Assessing clinical trials--trial size.BMJ, 1981
- Terminating a trial—the ethical problemClinical Pharmacology & Therapeutics, 1979
- The Importance of Beta, the Type II Error and Sample Size in the Design and Interpretation of the Randomized Control TrialNew England Journal of Medicine, 1978
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976
- XXXIV. The other side of ‘statistical significance’: alpha, beta. delta, and the calculation of sample sizeClinical Pharmacology & Therapeutics, 1975